CVS
NYSE · Health Care
Cvs Health Corp
$78.35
+2.02 (+2.65%)
Income Statement
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | 375.00B | 211.49B | 345.72B | 194.97B | 37.57B |
| Net Income | 4.64B | 2.62B | 3.85B | 2.17B | 4.63B |
| EPS | — | — | — | — | — |
| Profit Margin | 1.2% | 1.2% | 1.2% | 1.2% | 12.3% |
| Rev Growth | +8.5% | +8.5% | +8.5% | +8.5% | +20.5% |
Balance Sheet
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| Total Debt | 23.24B | 23.24B | 23.24B | 23.24B | 19.60B |
| Total Equity | 26.49B | 26.49B | 26.49B | 26.49B | 35.35B |
| D/E Ratio | 0.88 | 0.88 | 0.88 | 0.88 | 0.55 |
Cash Flow
| FY 2026 | FY 2026 | FY 2025 | FY 2025 | FY 2025 | |
|---|---|---|---|---|---|
| EBITDA | 9.16B | 5.17B | 8.02B | 4.52B | 5.39B |
| Free Cash Flow | — | — | — | — | 3.75B |